Bausch + Lomb Corp banner

Bausch + Lomb Corp
TSX:BLCO

Watchlist Manager
Bausch + Lomb Corp Logo
Bausch + Lomb Corp
TSX:BLCO
Watchlist
Price: 23.42 CAD 1.91% Market Closed
Market Cap: CA$8.2B

Relative Value

The Relative Value of one BLCO stock under the Base Case scenario is 60.35 CAD. Compared to the current market price of 23.42 CAD, Bausch + Lomb Corp is Undervalued by 61%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

BLCO Relative Value
Base Case
60.35 CAD
Undervaluation 61%
Relative Value
Price
Worst Case
Base Case
Best Case

Multiples Across Competitors

BLCO Competitors Multiples
Bausch + Lomb Corp Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CA
Bausch + Lomb Corp
TSX:BLCO
6B CAD 1.2 -19.7 19.6 92.4
JP
Hoya Corp
TSE:7741
9.6T JPY 10.5 38.4 27.8 33.4
US
Medline Inc
NASDAQ:MDLN
59.5B USD 0 0 0 0
CH
Alcon AG
SIX:ALC
30.3B CHF 3.9 38 15.7 30.5
DK
Coloplast A/S
CSE:COLO B
110.7B DKK 3.9 27.2 14.2 16.9
US
Align Technology Inc
NASDAQ:ALGN
14.2B USD 3.5 34.6 18.4 23.9
UK
ConvaTec Group PLC
LSE:CTEC
4.6B GBP 2.7 29.1 12.9 21
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
41.5B CNY 9.1 25.2 22.7 22.7
CH
Ypsomed Holding AG
SIX:YPSN
4.1B CHF 5.2 21.2 13.8 18.7
US
Merit Medical Systems Inc
NASDAQ:MMSI
4.8B USD 3.2 40.2 18.3 30.5
KR
HLB Inc
KOSDAQ:028300
6.9T KRW 85.2 -31.2 -72.4 -68.5
P/E Multiple
Earnings Growth PEG
CA
Bausch + Lomb Corp
TSX:BLCO
Average P/E: 31.7
Negative Multiple: -19.7
N/A N/A
JP
Hoya Corp
TSE:7741
38.4
13%
3
US
M
Medline Inc
NASDAQ:MDLN
Not Available N/A N/A
CH
Alcon AG
SIX:ALC
38
25%
1.5
DK
Coloplast A/S
CSE:COLO B
27.2
22%
1.2
US
Align Technology Inc
NASDAQ:ALGN
34.6
34%
1
UK
ConvaTec Group PLC
LSE:CTEC
29.1
33%
0.9
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
25.2
9%
2.8
CH
Ypsomed Holding AG
SIX:YPSN
21.2
32%
0.7
US
Merit Medical Systems Inc
NASDAQ:MMSI
40.2
30%
1.3
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -31.2 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CA
Bausch + Lomb Corp
TSX:BLCO
Average EV/EBITDA: 18.2
19.6
21%
0.9
JP
Hoya Corp
TSE:7741
27.8
11%
2.5
US
M
Medline Inc
NASDAQ:MDLN
Not Available N/A N/A
CH
Alcon AG
SIX:ALC
15.7
8%
2
DK
Coloplast A/S
CSE:COLO B
14.2
8%
1.8
US
Align Technology Inc
NASDAQ:ALGN
18.4
19%
1
UK
ConvaTec Group PLC
LSE:CTEC
12.9
10%
1.3
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
22.7
15%
1.5
CH
Ypsomed Holding AG
SIX:YPSN
13.8
21%
0.7
US
Merit Medical Systems Inc
NASDAQ:MMSI
18.3
16%
1.1
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -72.4 N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
CA
Bausch + Lomb Corp
TSX:BLCO
Average EV/EBIT: 32.2
92.4
60%
1.5
JP
Hoya Corp
TSE:7741
33.4
N/A N/A
US
M
Medline Inc
NASDAQ:MDLN
Not Available N/A N/A
CH
Alcon AG
SIX:ALC
30.5
23%
1.3
DK
Coloplast A/S
CSE:COLO B
16.9
8%
2.1
US
Align Technology Inc
NASDAQ:ALGN
23.9
N/A N/A
UK
ConvaTec Group PLC
LSE:CTEC
21
22%
1
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
22.7
11%
2.1
CH
Ypsomed Holding AG
SIX:YPSN
18.7
29%
0.6
US
Merit Medical Systems Inc
NASDAQ:MMSI
30.5
30%
1
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -68.5 N/A N/A